Previous studies by Tanaka et al. failed to show a significant difference in BTC mRNA between normal ovary and ovarian tumors [17], however most ovarian cancers are thought to arise from the fallopian tube epithelium or the ovarian surface epithelium [38, 39], and comparisons of BTC expression to these cell types have not been reported. This evidence concerns the gene BTC and ovarian carcinoma.